SCM
TMDX icon

Soleus Capital Management’s Transmedics TMDX Stock Holding History

Soleus Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,700
Closed -$1.23M – 109
2024
Q1 		$1.23M Sell
16,700
-106,412
-86% -$8.77M 0.09% 80
2023
Q4 		$9.72M Buy
+123,112
New +$7.43M 1.08% 30
2023
Q3 		– Sell
-74,200
Closed -$6.23M – 112
2023
Q2 		$6.23M Buy
74,200
+55,200
+291% +$4.23M 0.69% 42
2023
Q1 		$1.44M Sell
19,000
-24,500
-56% -$1.69M 0.15% 68
2022
Q4 		$2.68M Sell
43,500
-131,800
-75% -$7.01M 0.39% 50
2022
Q3 		$7.32M Sell
175,300
-9,155
-5% -$398K 0.99% 31
2022
Q2 		$5.8M Buy
+184,455
New +$4.92M 0.91% 36

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Soleus Capital Management's TMDX Position: Q2 2024 in Review

Soleus Capital Management sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 16,700 shares — an estimated $1.23M sold.

Soleus Capital Management first reported a position in TMDX in Q2 2022 and held it in 7 quarters. The position peaked at $9.72M in Q4 2023. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

  • Soleus Capital Management reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
  • Soleus Capital Management sold 16,700 Transmedics shares in Q2 2024, an estimated $1.23M.
  • Soleus Capital Management first reported a position in Transmedics in Q2 2022 and held it in 7 quarters.
  • Soleus Capital Management's Transmedics position peaked at $9.72M in Q4 2023.
  • 340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Soleus Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.